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Abstract A yeast two-hybrid screen identified Filamin-A as a
binding partner of the metabotropic glutamate receptor type 7b
(mGluR7b) splice variant. In addition, Filamin-A interacted with
mGluR4a, mGluR5a, mGluR5b, mGluR7a and mGluR8a.
Domain mapping revealed that alternative splicing of mGluR4,
mGluR7 and mGluR8 C-termini regulated the interaction. A
conserved tyrosine within mGluR C-termini was identified to
mediate the binding to Filamin-A. Protein interactions were
verified in biochemical assays using recombinant and native
proteins. Finally, co-expression of Filamin-A and mGluR7 splice
variants was shown in brain regions. These findings suggest that
Filamin-A may physically link metabotropic glutamate receptors
to the actin cytoskeleton. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Glutamate is the major excitatory neurotransmitter in the
mammalian central nervous system acting on ion channel-as-
sociated (ionotropic) and G-protein-coupled (metabotropic)
glutamate receptors. Metabotropic glutamate receptors
(mGluRs) in£uence a variety of intracellular second messen-
ger systems, modulating neuronal excitability, development,
synaptic plasticity and transmitter release [1]. To date eight
di¡erent mGluRs are known, which are subdivided into three
groups based on sequence homology, pharmacological prop-
erties and second messenger systems [2]. Group III mGluRs
(mGluR4, mGluR6, mGluR7, mGluR8) were primarily found
at presynaptic active zones where they may function as auto-
receptors [3^8]. Remarkably, mGluR7 in the hippocampus
was localized at di¡erent densities at synaptic terminals of
the same axon depending on the nature of the postsynaptic
neuron [6,7]. Similarly, in retinal axon terminal systems of
bipolar cell ribbon synapses the expression of mGluR7 was
restricted to one side of the active zone [8].
Synaptic neurotransmission requires a highly ordered
arrangement of neurotransmitter receptors at subcellular spe-
cializations. Mechanisms mediating the synaptic localization
of mGluR7 are unknown. The intracellular C-terminus is im-
portant for targeting of mGluR7 [9,10] and recently, proteins
interacting with this domain were identi¢ed: calmodulin,
PICK1 (protein interacting with C-kinase) and PKC (protein
kinase C) [11^16]. Here, a yeast two-hybrid screen showed
interaction of Filamin-A, a member of the K-actinin/spec-
trin/dystrophin family of actin-binding proteins, with the
mGluR7b C-terminus. Filamin-A induces polymerization of
actin ¢laments by crosslinking them into orthogonal arrays
or parallel ¢bers, contributing to the formation of the actin
meshwork adjacent to the surface cell membrane [17]. Re-
cently, Filamin-A was found to bind dopamine receptors
and voltage-gated potassium channels, thus physically con-
necting neurotransmitter receptors and ion channels to the
actin cytoskeleton [18,19].
2. Materials and methods
2.1. Yeast two-hybrid techniques
The mGluR7b C-terminus of rat (amino acids 851^922) was sub-
cloned in pBTM116 for expression as a LexA fusion protein. Yeast
L40 (Invitrogen) cells were sequentially transformed with the bait and
1 mg of bovine retinal cDNA library in pVP16 [20]. Colonies were
grown for 5 days at 30‡C on selection plates containing 3 mM 3-
amino-1,2,4-triazole, then transferred to plates containing 5-bromo-
4-chloro-3-indoxyl-L-D-galactopyranoside. Library plasmids of posi-
tive clones were isolated and sequenced. To map interacting domains,
ampli¢ed DNA fragments were subcloned in appropriate yeast vec-
tors. MGluR7 point mutations were introduced by PCR: sense
5P-CGGGATCCACCCTGAACTCAATGTC-3P, antisense Y916S 5P-
AACTGCAGCTATACTGTTGGTGGGATAGTACTCCAAGTTA-
CGGACTTTTGTAC-3P, antisense Y916F 5P-AACTGCAGCTAT-
ACTGTTGGTGGGATAGTAAACCAAGTTACGGACTTTTGTA-
C-3P (restriction sites are bold, mutated codons underlined). Yeast
transformations and quanti¢cation of protein^protein interactions
were performed according to the ‘Yeast Protocolls Handbook’ (Clon-
tech). A shaker L1-domain (aa 1^227, rat sequence) was used for
controls. (Plasmids and cDNA were gifts of Drs. Jeremy Nathans
and Min Li, Johns Hopkins University, Baltimore, MD, USA.)
2.2. Glutathione-S-transferase (GST) pull-down assays
MGluR C-termini (rat sequences) were ligated to the coding se-
quence of GST of pET-41 (Novagen), expressed in Escherichia coli
BL21(DE3)pLysS and immobilized on glutathione Sepharose. Cal-
modulin (rat) and Filamin-A (bovine) were T7-tagged by cloning in
pET-21 (Novagen). Membrane protein extracts of human embryonic
kidney cells (HEK-293, ATCC CRL1573) were prepared as described
[21]. Binding assays were performed according to the manufacturer’s
protocol (Novagen). For calmodulin, solutions were supplemented
with 1 mM CaCl2 or 5 mM EGTA. Bound proteins were eluted by
boiling in SDS sample bu¡er, separated by SDS^PAGE, Coomassie-
stained or detected by Western blotting and chemoluminescence
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(ECL; Amersham) using anti-T7 (1:10 000; Novagen) and anti-Fila-
min-A (1:200; Dianova) as primary antibodies.
2.3. Immunocytochemistry
Staining of HEK-293 cells was performed as described [22], using a
Filamin-A-speci¢c immunserum (1:300; Dianova) and Cy3-conju-
gated goat anti-mouse antibodies (1:500, Dianova). Immuno£uores-
cence was accomplished with an epi£uorescence microscope (Axio-
skop, Zeiss) and a cooled coupling device (CCD camera C4742-95,
Hamamatsu).
2.4. RT-PCR
RNA puri¢cation, cDNA synthesis and PCR were performed as
reported [23]. Total RNA was extracted from adult rat brain regions
or HEK-293 cells and reverse transcribed. For PCR, oligonucleotides
speci¢c for Filamin-A (sense 5P-CCATCACTGACAACAAAGATG-
3P, nt 5456^5478; antisense 5P-CTCAATGGCCAGAGACAAGC-3P,
nt 5709^5690), mGluR7a (sense 5P-CACCCTGAACTCAATGTC-
CAG-3P, nt 2551^2571; antisense 5P-TTAGATAACCAGGTTATTA-
TAACTG-3P, nt 2748^2724), mGluR7b (sense 5P-CACCCTGAACT-
CAATGTCCAG-3P, nt 2551^2571; antisense 5P-CTATACTGT-
TGGTGGGATAGTG-3P, nt 2769^2748) and L-actin (sense 5P-TGA-
GACCTTCAACACCCCAG-3P, nt 372^391; antisense 5P-GTAGAC-
GACCTTCCACCTGT-3P, nt 1065^1046) were used. For HEK-293
cDNA, Filamin-A-speci¢c PCR primers were: sense 5P-CTGTG-
GCTTCTCCGTCTG-3P, nt 6972^6989; antisense 5P-AACTCG-
GATCTTGAAGGGGC-3P, nt 7262^7243). Southern blot oligonu-
cleotides for Filamin-A (5P-CTGTTACTGTGCGTTACTCAC-3P, nt
5482^5502), mGluR7a, mGluR7b (5P-GTTTGGGTCTACATTTT-
CACAG-3P, nt 2655^2676) and L-actin (5P-CGGTCAGGTCATCAC-
TATC-3P, nt 732^750) were tailed with DIG-ddUTP, hybridized and
detected following the protocol of the manufacturer (Roche).
3. Results
3.1. Identi¢cation of Filamin-A as a binding partner of
mGluR7b
A yeast two-hybrid screen for the mGluR7b C-terminus
generated V3U106 primary transformants, of which 100 can-
didates were further analyzed. Clone 44 reproducibly inter-
acted with mGluR7b, but not with control plasmids. Sequenc-
ing identi¢ed an open reading frame of the actin-binding
protein Filamin-A (aa 2178^2647), followed by the 3P-untrans-
lated region. The coding region varied little between bovine
(GenBank accession number AY072716), human [24] and
mouse sequences (GenBank accession number BC004061),
most changes being conservative. Serine-2446 forms a putative
consensus sequence for casein kinase-2 in bovine and mouse,
but is absent in human. The bovine 3P-untranslated region
di¡ered by 48 and 61% from human and mouse genes, respec-
tively.
3.2. Filamin-A interacts with splice variants of mGluR family
members
To investigate whether Filamin-A interacts with other
mGluR family members, their C-termini were individually
tested in binding assays (Fig. 1). Protein interactions were
monitored by the ability of transformed yeast cells to grow
on selective media containing 5-bromo-4-chloro-3-indoxyl-L-
D-galactopyranoside, supplemented with either no or 3 mM 3-
amino-1,2,4-triazole, indicating weak or strong binding a⁄n-
ities. Robust interaction with Filamin-A was observed for
mGluR5a, 5b, 7b and 8a, while mGluR4a and 7a showed
lower a⁄nities (Fig. 1A). The mGluR1a C-terminus self-acti-
vated yeast reporter genes, as already reported [25]. MGluR6
was the only group III member not binding to Filamin-A.
This is consistent with its unique expression in retinal bipolar
cell dendrites, suggesting a speci¢c mechanism mediating this
localization [26]. Relative strengths of protein^protein inter-
actions were calculated as arbitrary L-galactosidase units.
Strongest binding was observed for mGluR5a (490 þ 102)
and mGluR5b (531 þ 25), values were lower for mGluR7b
(200 þ 50) and mGluR8a (155 þ 156) whereas mGluR4a
(8.4 þ 1.4) and mGluR7a (22.5 þ 7.7) showed weakest a⁄nities
(Fig. 1A). For a control, the selective binding of group I
mGluRs to Homer 1a was tested. As reported [27], mGluR5
(group I), but not mGluR4, mGluR7 and mGluR8 (group
III), did bind to Homer 1a.
Since mGluR/Filamin-A interactions might depend on al-
ternative splicing, domains representing identical or di¡erent
regions within C-terminal tails were tested individually (Fig.
1B). The Filamin-A/mGluR5 interaction appeared indepen-
dent of the splice variant, since an identical region (aa 827^
875) revealed a binding strength of 473 þ 26, similar to the
Fig. 1. Filamin-A binds to mGluR C-termini: MGluR C-termini
(A), proximal and distal regions (B) or mutated domains (C) were
individually tested in binary two-hybrid experiments for their ability
to interact with Filamin-A (aa 2178^2647). The seven transmem-
brane regions of mGluR7 are visualized as black boxes, C-termini
are drawn to scale and corresponding amino acid numbers are given
in brackets. The arrow in (C) indicates the conserved tyrosine mu-
tated in mGluR7b. Diagrams show activation of yeast reporter
genes on selective media without (+) or with 3 mM 3-amino-1,2,4-
triazole (+++); sa, self-activating. A⁄nities were quanti¢ed as arbi-
trary L-galactosidase units. Values represent the mean of three yeast
colonies and are expressed as þ S.E.M.
FEBS 25835 28-3-02
R. Enz/FEBS Letters 514 (2002) 184^188 185
complete C-termini. This Filamin-A-binding site di¡ers from
the domain interacting with Homer (aa 1122^1129) [27], sug-
gesting that Filamin-A and Homer do not compete for
mGluR5 binding. Interaction of mGluR4, mGluR7 and
mGluR8 with Filamin-A depended on the splice variant,
with a⁄nities of 40.4 þ 17.2 and 396 þ 125 for the distal splice
variant-speci¢c domains of mGluR7b and mGluR8a (Fig.
1B). The variant-speci¢c domain of mGluR7a did not bind
Filamin-A and the proximal part interacted extremely weak
(0.26 þ 0.1), indicating that both regions contained binding
sites needed in combination for the Filamin-A/mGluR7a as-
sociation.
The speci¢c interaction of Filamin-A with a subset of
mGluRs allowed the identi¢cation of amino acids important
for the binding. Alignment of interacting and non-interacting
distal regions of mGluR C-termini identi¢ed a tyrosine (Y916
of mGluR7b), which is conserved in Filamin-A-binding C-
termini, but is absent in the non-interacting mGluR8b (Fig.
1C). To test if size or hydroxyl group of Y916 are important
determinants for Filamin-A binding, Y916 was mutated into
serine (Y916S) or phenylalanine (Y916F). While Y916S abol-
ished the mGluR7b/Filamin-A interaction, Y916F did not sig-
ni¢cantly alter the binding strength (252 þ 19.1) compared to
wild-type mGluR7b (220 þ 28.8; Fig. 1C). Consistent with this
¢nding, the tyrosine is conserved in all group III mGluRs
binding to Filamin-A, but is absent in the non-interacting
mGluRs [13].
3.3. Mapping domains of Filamin-A binding to mGluRs
Filamin-A consists of a rod-like structure composed of 24
homologous repeats, separated by two ‘hinge’ regions [24].
According to this modular structure, successive N- or C-ter-
minal deletions were introduced to identify regions binding to
mGluRs (Fig. 2). Truncating repeat 21 or 22 abolished inter-
action, indicating that sequences in these two domains were
important for Filamin-A/mGluR association. Supporting this
hypothesis, a construct containing repeats 21 and 22 (F21^22)
did bind to all mGluR C-termini tested. Binding (mGluR4a:
0.82 þ 0.33; mGluR5a: 223 þ 18.2; mGluR5b: 336 þ 20.2;
mGluR7a: 1.1 þ 0.3; mGluR7b: 31.7 þ 8.8; mGluR8a:
45.8 þ 13.7) was weaker compared to repeats 20^24, thus
F21^22 might represent a minimal binding motive, while in
the full-length protein additional domains could play some
role in the formation of the complex. Interestingly, the dimer-
ization domain (repeat 24) of Filamin-A [24], as well as the
actin-binding domain, were not involved in mGluR binding,
allowing dimerization and cytoskeleton association of Fila-
min-A to happen independent of mGluR binding.
3.4. Recombinant and native Filamin-A bind to mGluR7
C-termini
To con¢rm the Filamin-A/mGluR interactions, pull-down
assays were performed using GST-mGluR7a and GST-
mGluR7b fusion proteins immobilized on glutathione Sephar-
ose incubated with E. coli protein extracts. Reliability of the
pull-down assay was tested using the calcium-dependent bind-
ing of calmodulin to mGluR7. As reported [11], interaction
was observed in the presence of calcium but not in the pres-
ence of the calcium chelator EGTA (Fig. 3A). When mGluR
C-termini were incubated with Filamin-A (aa 2178^2647),
binding was observed for mGluR7 splice variants but not
for GST (Fig. 3B), consistent with the yeast-binding studies.
To test whether full-length Filamin-A was able to bind
mGluR7, HEK-293 cells were identi¢ed to express endoge-
nous concentrations of Filamin-A detectable by RT-PCR
(Fig. 3C) and immunostaining (Fig. 3D). Incubation of
mGluR C-termini with HEK-293 protein extracts demon-
strated binding of mGluR7 to native Filamin-A (Fig. 3E).
Fig. 2. Domain mapping of Filamin-A: Deletion constructs of Fila-
min-A (aa 2178^2647) were tested for binding to mGluR C-termini
as described in Fig. 1. Filamin-A repeats are indicated by numbers;
ABD, actin-binding domain; H, hinge; nd, not determined.
Fig. 3. Recombinant and native Filamin-A binds to mGluR7: GST
fusion proteins immobilized on glutathione Sepharose were incu-
bated with T7-tagged proteins (A, B) or with membrane-bound frac-
tions of HEK-293 cells (E). Coomassie-stained gels show equal in-
put of fusion proteins (arrowheads in A, B, E). Interacting proteins
identi¢ed in Western blots are indicated as Cal (17 kDa) ^ calmodu-
lin; FLNA (52 kDa) ^ recombinant Filamin-A; FLNA (250 kDa) ^
native Filamin-A. Filamin-A expression in HEK-293 cells was de-
tected by RT-PCR (C) and immunostaining (D, white bar is 10
Wm).
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3.5. Localization of Filamin-A, mGluR7a and mGluR7b in the
brain
Since physiological interaction of Filamin-A with mGluR7
requires the presence of binding partners in the same tissue,
their expression was analyzed in various brain tissues. Fila-
min-A was present in retina and hippocampus, where asym-
metric synaptic localization of mGluR7 has been reported
[6^8], as well as in other brain regions, with slightly higher
concentrations in olfactory bulb, cerebellum and spinal cord
(Fig. 4A). Highest expression for mGluR7a was visible in
cortex and thalamus (Fig. 4B), whereas transcripts for
mGluR7b were enriched in cortex and hippocampus (Fig.
4C). Approximately equal amounts of cDNA from each tissue
were used, as demonstrated by the similar intensity of L-actin
PCR products (Fig. 4D).
4. Discussion
This study identi¢ed Filamin-A as a new binding partner of
mGluR C-termini. Filamin-A has been co-localized with ace-
tylcholine receptor clusters in cultured chick myotubes and
has been proposed to play a role in agrin-mediated acetylcho-
line receptor clustering at neuromuscular junctions [28]. Re-
cent studies demonstrated binding of Filamin-A to dopamine
receptors D2 and D3 as well as to the voltage-gated potassium
channel Kv4.2 [18,19]. Based on these ¢ndings, a sca¡olding
function for Filamin-A in formation and maintenance of mac-
romolecular complexes at synapses has been proposed. Ac-
cording to a recent model, induction of ¢lopodial-like precur-
sors under synaptic axonal boutons results in the formation of
dendritic spines [29], and indeed, Filamin-A is highly concen-
trated at cellular ¢lopodial roots [30]. Considering the data of
this study, mGluR7 might represent a new member of Fila-
min-A containing synaptic complexes.
Proteins binding to mGluR7 include PKCK, calmodulin
and PICK1 [11^16]. Calmodulin and a G-protein LQ-subunit
compete for binding to the mGluR7 C-terminus [11^13]. This
binding site was located in the proximal part of the C-termi-
nus, distinct from the Filamin-A-binding region. Thus,
mGluRs could be linked to the cytoskeleton via Filamin-A
independent of G-protein binding. In contrast, the binding
motive for PICK1 was localized to the C-terminal 15 amino
acids of mGluR7 [16], including the conserved tyrosine resi-
due identi¢ed in this study. PICK1 interacts with PKCK and
phosphorylation of mGluR7 has been demonstrated [13,31].
Therefore, the exclusive association of Filamin-A or PICK1/
PKCK with mGluR7 could regulate phosphorylation of the
mGluR7 C-terminus.
Within cells, Filamin-A exists in two di¡erent pools de-
pending on its phosphorylation status, one being associated
with the plasma membrane, the other crosslinking the actin
cytoskeleton [19]. Since kinase activity can be in£uenced by
synaptic signaling via second messenger systems, mGluR7
could regulate Filamin-A concentrations at synapses, thereby
controlling the synaptic presence of cytoskeletal associated
proteins.
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